COVID-19 UPDATES • 5/12/2022
All of the latest news about our university. (by topic)
Paxlovid, the COVID-19 medicine developed by Pfizer, is being evaluated in Western New York in children who are symptomatic with COVID-19 infection, and who are at risk of progression to severe disease.
Annette Wysocki has extensive leadership, exceptional research and teaching accomplishments and a deep understanding of the challenges and opportunities in the field of nursing.
Students from the College of Arts and Sciences graduated on Sunday, May 22 as many were also were recognized with awards of the highest honors.
In the ‘eternal arms race’ between pathogen and host, cells employ the same gene to fight both SARS-CoV-2 and HIV, revealing new avenues for potential therapies.
New research explores ‘technological entitlement.’
Patients hospitalized with COVID-19 pneumonia had a 13.5% survival advantage when treated with a combination of leukotriene inhibitors (LTIs) and the steroid dexamethasone.
The effort uses AI, big data and other tools; could aid semiconductor, 3D printing and other industries.
During its commencement ceremonies, the UB School of Management recognized 17 outstanding graduates for their academic, extracurricular or volunteer accomplishments.
UB is sponsoring a virtual talk on “The COVID-19 Vaccines: Science vs. Anti-science” by prominent vaccine scientist and “misinformation antagonist” Peter J. Hotez, MD, PhD, on June 9 at noon.
Monique Kapur-Mauleon will begin a five-year degree program that combines a master’s in oral sciences with a doctor of dental surgery from the UB School of Dental Medicine.
Read the latest in your favorite channels.
Take UB With You. Wherever.